Jasbir Seehra

Jasbir Seehra has served as Chief Executive Officer and as a member of the board of directors since December 2015. Prior to joining Keros, Dr. Seehra was the Chief Scientific Officer at Ember Therapeutics and was the Co-Founder and Chief Scientific Officer of Acceleron Pharma. Previously, he was Vice President of Biological Chemistry at Wyeth and led the small molecule lead discovery effort at Genetics Institute, where he helped build their small molecule drug discovery capabilities, including medicinal chemistry, high throughput screening and structural biology. Dr. Seehra received a B.Sc. and a Ph.D. in Biochemistry from the University of Southampton in England and completed his postdoctoral work at the Massachusetts Institute of Technology. Dr. Seehra serves on the board of directors of Eloxx Pharmaceuticals.